PinnyPeptide

Glow Blend (BPC-157 + TB-500 + GHK-Cu) vs TB-500

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Glow Blend (BPC-157 + TB-500 + GHK-Cu)

Peptide Blends

Wolverine's healing duo plus GHK-Cu — soft-tissue recovery with a cosmetic kicker for skin, hair, and scars.

Peptide B

TB-500

Healing & Recovery

Synthetic fragment of Thymosin Beta-4 with potent tissue repair activity.

Typical vial

70 mg

Typical dose

250 + 2000 + 1000 (BPC + TB + GHK) mcg

Half-life

BPC-157 ~4 h; TB-500 ~6-8 h; GHK-Cu ~minutes systemically (longer in tissue)

FDA status

No component FDA approved for human use. FDA issued a warnin…

Typical vial

5 mg

Typical dose

2000-5000 mcg

Half-life

~6-8 hours

FDA status

Not FDA approved for human use.

Glow Blend (BPC-157 + TB-500 + GHK-Cu) effects

  • Soft-tissue healing and tendon recovery (BPC + TB contribution)
  • Stimulates collagen synthesis and skin elasticity (GHK-Cu contribution)
  • Reduces scar formation and supports scar remodelling
  • Promotes hair-follicle health and may support regrowth
  • Angiogenesis and improved blood flow to repair sites
  • Modulates inflammation across all three pathways

TB-500 effects

  • Promotes wound healing and tissue repair
  • Reduces inflammation and fibrosis
  • Stimulates new blood vessel growth
  • Supports cardiac repair after ischemic injury
  • Enhances cell migration through actin upregulation

Glow Blend (BPC-157 + TB-500 + GHK-Cu) side effects

  • Injection site irritation, occasionally with mild bluish tint from copper
  • Temporary lightheadedness
  • Mild lethargy in first 1-2 weeks
  • Headache
  • Nausea at upper dosing range
  • Rare metallic taste reported with GHK-Cu

TB-500 side effects

  • Injection site irritation
  • Temporary head rush or lightheadedness
  • Mild lethargy
  • Headache

Glow Blend (BPC-157 + TB-500 + GHK-Cu) dosing ranges

Recovery + cosmetic loading

250 mcg BPC + 2 mg TB-500 + 1-2 mg GHK-Cu · BPC daily, TB-500 twice weekly, GHK-Cu daily · 6-8 weeks

Scar remodelling protocol

250 mcg BPC + 2 mg TB-500 + 2 mg GHK-Cu · BPC daily, TB-500 weekly, GHK-Cu daily (site-local) · 8-12 weeks

Maintenance stack

250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · BPC 3-4x weekly, others weekly · Ongoing cycles

TB-500 dosing ranges

Acute injury healing

2000-5000 mcg · Twice weekly · 4-6 weeks

Maintenance and recovery

2000 mcg · Once weekly · 4-8 weeks

Full Glow Blend (BPC-157 + TB-500 + GHK-Cu) guide → Full TB-500 guide →

Glow Blend (BPC-157 + TB-500 + GHK-Cu) vs TB-500 — common questions

What is the difference between Glow Blend (BPC-157 + TB-500 + GHK-Cu) and TB-500?

Glow Blend (BPC-157 + TB-500 + GHK-Cu): Wolverine's healing duo plus GHK-Cu — soft-tissue recovery with a cosmetic kicker for skin, hair, and scars. Typical dose 250 + 2000 + 1000 (BPC + TB + GHK) mcg. TB-500: Synthetic fragment of Thymosin Beta-4 with potent tissue repair activity. Typical dose 2000-5000 mcg. Both fall under the Peptide Blends and Healing & Recovery categories.

Can you stack Glow Blend (BPC-157 + TB-500 + GHK-Cu) and TB-500?

Stacking Glow Blend (BPC-157 + TB-500 + GHK-Cu) with TB-500 is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Glow Blend (BPC-157 + TB-500 + GHK-Cu) or TB-500?

Glow Blend (BPC-157 + TB-500 + GHK-Cu) is typically dosed: BPC daily, TB-500 twice weekly, GHK-Cu daily for Recovery + cosmetic loading; BPC daily, TB-500 weekly, GHK-Cu daily (site-local) for Scar remodelling protocol; BPC 3-4x weekly, others weekly for Maintenance stack. TB-500 is typically dosed: Twice weekly for Acute injury healing; Once weekly for Maintenance and recovery.

Are Glow Blend (BPC-157 + TB-500 + GHK-Cu) and TB-500 FDA approved?

Glow Blend (BPC-157 + TB-500 + GHK-Cu): No component FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products. TB-500: Not FDA approved for human use.

Related peptide comparisons

bpc-157 vs glow-blendghk-cu vs glow-blendglow-blend vs klow-blendglow-blend vs wolverine-blendara-290 vs tb-500b7-33 vs tb-500

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free